Stock PASG PASSAGE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Passage Bio, Inc.

Equities

PASG

US7027121000

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
1.325 USD -10.47% Intraday chart for Passage Bio, Inc. -16.14% +31.19%
03-04 Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-04 Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PASSAGE BIO, INC. Stock Passage Bio, Inc.
 91.19M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 22.34B -
ARGENX SE Stock argenx SE
 21.93B -
GENMAB A/S Stock Genmab A/S
 18.59B
  1. Stock Market
  2. Equities
  3. PASG Stock
  4. Charts Passage Bio, Inc.
  5. Sector Chart